References
- Karikura M, Miyase T, Tanizawa H, Taniyama T, Takino Y. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of ginsenoside-Rbi and -Rb2 in the digestive tract of rats. Chem Pharm Bull 1991; 39: 2357–61.
- Tanizawa H, Karikura M, Miyase T, Takino Y. Studies on the metabolism and/or decomposition and distribution of gin-senoside Rb2 in rats. Proc 6th Int Ginseng Symp, Seoul 1993: 187–194.
- Hasegawa H, Sung JH, Matsumiya S, Uchiyama M. Main Ginseng saponin metabolites formed by intestinal bacteria. Planta Med 1996; 62: 453–7.
- Akao T, Kanaoka M, Kobashi K. Appearance of compound K, a major metabolite of ginsenoside Rbi by intestinal bacteria, in rat plasma after oral administration: Measurement of compound K by enzyme immunoassay. Biol Pharm Bull 1998; 21: 245–9.
- Akao T, Kida H, Kanaoka M, Hattori M, Kobashi K. Intestinal bacterial hydrolysis is required for appearance of compound K in rat plasma after oral administration of gin-senoside Rbi from Panax ginseng. J Pharm Pharmacol 1998; 50: 1155–60.
- Wakabayashi C, Hasegawa H, Murata J, Saiki I. In vivo antimetastatic action of Ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral admin-istration. Oncol Res 1997; 9: 411–7.
- Wakabayashi C, Hasegawa H, Murata J, Saiki I. The expres-sion of in vitro anti-metastatic effect of Ginseng protopanaxa-triol saponins is mediated by their intestinal bacterial metabolites after oral administration. J Tradit Med 1997; 14: 180–5.
- Hasegawa H, Uchiyama M. Antimetastatic efficacy of orally administered ginsenoside Rbi in dependence on intestinal bacterial hydrolyzing potential and significance of treatment with an active bacterial metabolite. Planta Med 1998; 64: 696–700.
- Ahn YO. Diet and stomach cancer in Korea. Int J Cancer Suppl 1997; 10: 7–9.
- Yun TK. Experimental and epidemiological evidence of the cancer preventive effects of Panax ginseng C.A. Meyer. Nutri-tion Rev 1996; 54 (II): S71–81.
- Itoh K, Mitsuoka T, Sudo K, Suzuki K. Comparison of fecal flora of mice based upon different strains and different housing conditions. Z Versuchstierk 1983; 25: 135–46.
- Pretlow TP, Barrow BJ, Ashton WS, O'Riordan MA, Pretlow TG, Jurcisek JA, Stellato TA. Aberrant crypts: Putative pre-neoplastic foci in human colonic mucosa. Cancer Res 1991; 51: 1564–7.
- Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings. Cancer Lett 1987; 37: 147–51.
- McLellan EA, Medlin A, Bird RP. Sequential analysis of the growth and morphological characteristics of aberrant crypt foci: Putative preneoplastic lesions. Cancer Res 1991; 51: 5270–4.
- Thumherr N, Deschner EE, Stonehill EH, Lipkin M. Induction of adenocarcinomas in the colon in mice by weekly injection of 1,2-dimethylhydrazine. Cancer Res 1973; 33: 940–5.
- Mitsuoka T, Sega T, Yamamoto S. Eine verbesserte Methodik der qualitativen und quantitativen Analyse der Darmflora von Menshen und Tieren. Zentralbl Bakteriol Parasitenkd In-fekionskr Hyg I Orig 1964; 195: 455–69.
- Mitsuoka T, Ohno K, Benno Y, Suzuki K, Namba K. Die Faekalflora bei Menschen. IV Mitteilung: Vergleich des neu entwickelten Verfahrens mit dem bisherigen iiblichen Ver-fahren zur Darmfloraanalyse. Zentralbl Bakteriol Parasitenkd Infekionskr Hyg I Orig 1976; 234: 219–33.
- Itoh K, Mitsuoka T. Production of gnotobiotic mice with normal physiological functions: I. Selection of useful bacteria from feces of conventional mice. Z Versuchstierkd 1980; 22: 173–8.
- Hasegawa H, Sung JH, Benno Y. Role of human intestinal Prevotella oris in hydrolyzing Ginseng saponins. Planta Med 1997; 63: 436–40.
- Hasegawa H, Lee KS, Nagaoka T, et al. Pharmacokinetics of ginsenoside deglycosylated by intestinal bacteria and its trans-formation to biologically active fatty acid esters. Biol Pharm Bull 2000; 23: 298–304.
- Benno Y, Suzuki K, Narisawa K, Bruce WR, Mitsuoka T. Comparison of the fecal microflora in rural Japanese and urban Canadians. Microbiol Immunol 1986; 30: 521–32.
- Benno Y, Endo K, Mizutani T, Namba Y, Komori T, Mit-suoka T. Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl Environ Microbiol 1989; 55: 1100–5.
- Itoh K, Matsui T, Tsuji K, Mitsuoka T, Ueda K. Genetic control in the susceptibility of germfree inbred mice to infec-tion by Escherichia coli 0115a, c: K (B). Infec Immun 1988; 56: 930–5.
- Itoh K, Oowada T, Mitsuoka T, Sudo K, Suzuki S. Studies on the genetic and hormonal control of Lactobacillus populations in feces on mice. Microecol Ther 1989; 19: 117–8.
- Wakabayashi C, Murakami K, Hasegawa H, Murata J, Saiki I. An intestinal bacterial metabolite of Ginseng protopanaxa-diol saponins has the ability to induce apoptosis in tumor cells. Biochem Biophys Res Commun 1998; 246: 725–30.
- Lee BH, Lee SJ, Hui JH, et al. In vitro antigenotoxic activity of novel Ginseng saponin metabolites formed by intestinal bacteria. Planta Med 1998; 64: 500–3.
- Lee BH, Lee SJ, Ko WG, et al. A novel intestinal bacterial metabolite of Ginseng saponin induces apoptosis in human myeloid leukemia cells by activation of caspase-3 protease. accepted in Biochem Pharmacol.
- Yun YS, Lee YS, Jo SK, Jung IS. Inhibition of autochthonous tumor by ethanol insoluble fraction from Panax ginseng as an immunomodulator. Planta Med 1993; 59: 521–4.